The Global Moist Wound Dressings Market size is expected to reach $6.2 billion by 2030, rising at a market growth of 5.4% CAGR during the forecast period. In the year 2022, the market attained a volume of 1234.0 million Units, experiencing a growth of 5.1% (2019-2022).
The hydrocolloid dressings are widely used for the treatment of mildly exuding wounds. Hence, the hydrocolloid dressings segment would capture approximately 1/5th share of the market by 2030. These dressings contribute to healing by creating a moist environment around the cut. In addition to providing an occlusive barrier over the lesion, hydrocolloid dressings protect it from external pollutants, bacteria, and other pathogens. Because these dressings are flexible and adapt well to the body's contours, they can be used in various anatomical locations. They are simple to apply to areas with uneven surfaces, such as the elbows, knees, and soles. Some of the factors impacting the market are increasing awareness of wound care in emerging countries, growing risk of wound-related complications in ageing population, and high cost of wound treatment.
In developing nations, the demand for advanced wound care products is growing significantly due to increased wound care management awareness, a rise in the geriatric population, and the majority of chronic conditions. The demand may also be driven by healthcare initiatives that aim to educate healthcare providers and caregivers in emerging countries about proper wound care techniques, including moist dressings. Emerging countries may experience demographic shifts with aging populations, leading to an increased incidence of chronic conditions and chronic wounds, further driving the demand for advanced wound care products like moist dressings. The WHO reports that people are living longer overall. Most people today plan to live until their sixties and beyond. The increasing demand driven by the aging population has spurred research and innovation in the wound care industry. Manufacturers are developing new and improved products specifically tailored to the needs of older patients, further enhancing the market's growth. As the global population ages, there is a higher likelihood of developing wounds and chronic conditions that require wound care. This demographic shift has contributed to the growth of the market.
However, the high cost of wound treatment, which may include wet dressings, could create a challenge for the market. Patients and the entire healthcare system bear a heavy cost burden due to chronic, challenging-to-heal skin lesions such as pressure sores, burning, and diabetic foot ulcers. Manufacturers of moist wound dressings may face pressure to control costs while maintaining product quality and innovation. Balancing these factors can be challenging, and cost-containment efforts may impact product availability and pricing. Due to these factors, the market growth may be hampered in the coming years.
Moreover, the COVID-19 pandemic had a mixed impact on the moist wound dressings market. While increased awareness of infection control and the growing use of telemedicine positively influenced demand, supply chain disruptions, delayed elective procedures, and economic constraints posed challenges. Many hospitals and healthcare facilities postponed elective surgeries and procedures to allocate resources to COVID-19 patients. This reduced demand for wound care products, including moist dressings, as fewer surgeries led to fewer surgical wounds. Moist wound dressings were used to manage these wounds effectively. The long-term effects of the pandemic on the moist wound dressings market depend on factors such as the pace of recovery, healthcare system resilience, and ongoing developments in wound care practices.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Coloplast Group, Medline Industries, Inc., Smith & Nephew PLC, Convatec, Inc., Essity AB, Integra LifeSciences Holdings Corporation, Cardinal Health, Inc., Molnlycke Health Care AB, 3M Company, B. Braun Melsungen AG
The hydrocolloid dressings are widely used for the treatment of mildly exuding wounds. Hence, the hydrocolloid dressings segment would capture approximately 1/5th share of the market by 2030. These dressings contribute to healing by creating a moist environment around the cut. In addition to providing an occlusive barrier over the lesion, hydrocolloid dressings protect it from external pollutants, bacteria, and other pathogens. Because these dressings are flexible and adapt well to the body's contours, they can be used in various anatomical locations. They are simple to apply to areas with uneven surfaces, such as the elbows, knees, and soles. Some of the factors impacting the market are increasing awareness of wound care in emerging countries, growing risk of wound-related complications in ageing population, and high cost of wound treatment.
In developing nations, the demand for advanced wound care products is growing significantly due to increased wound care management awareness, a rise in the geriatric population, and the majority of chronic conditions. The demand may also be driven by healthcare initiatives that aim to educate healthcare providers and caregivers in emerging countries about proper wound care techniques, including moist dressings. Emerging countries may experience demographic shifts with aging populations, leading to an increased incidence of chronic conditions and chronic wounds, further driving the demand for advanced wound care products like moist dressings. The WHO reports that people are living longer overall. Most people today plan to live until their sixties and beyond. The increasing demand driven by the aging population has spurred research and innovation in the wound care industry. Manufacturers are developing new and improved products specifically tailored to the needs of older patients, further enhancing the market's growth. As the global population ages, there is a higher likelihood of developing wounds and chronic conditions that require wound care. This demographic shift has contributed to the growth of the market.
However, the high cost of wound treatment, which may include wet dressings, could create a challenge for the market. Patients and the entire healthcare system bear a heavy cost burden due to chronic, challenging-to-heal skin lesions such as pressure sores, burning, and diabetic foot ulcers. Manufacturers of moist wound dressings may face pressure to control costs while maintaining product quality and innovation. Balancing these factors can be challenging, and cost-containment efforts may impact product availability and pricing. Due to these factors, the market growth may be hampered in the coming years.
Moreover, the COVID-19 pandemic had a mixed impact on the moist wound dressings market. While increased awareness of infection control and the growing use of telemedicine positively influenced demand, supply chain disruptions, delayed elective procedures, and economic constraints posed challenges. Many hospitals and healthcare facilities postponed elective surgeries and procedures to allocate resources to COVID-19 patients. This reduced demand for wound care products, including moist dressings, as fewer surgeries led to fewer surgical wounds. Moist wound dressings were used to manage these wounds effectively. The long-term effects of the pandemic on the moist wound dressings market depend on factors such as the pace of recovery, healthcare system resilience, and ongoing developments in wound care practices.
Application Outlook
Based on application, the market is fragmented into acute wounds and chronic wounds. In 2022, the chronic wounds segment registered the highest revenue share in the market. This can be attributed to the increasing prevalence of chronic lesions and the demand for novel treatment options. Rising numbers of sports injuries, a growing incidence of diabetes, and modifications to lifestyles are anticipated to drive segment growth. Reduced vascular activity in adipose tissue increases the risk of pressure ulcers for obese individuals. These patients' inability to reposition themselves in bed is a risk factor for pressure-related injuries. In addition, the skin folds on their bodies provide optimal conditions for the growth of microorganisms.End-Use Outlook
By end-use, the market is categorised into hospitals, speciality clinics, home healthcare, and others. This expansion can be attributed to the increasing number of surgical procedures in these facilities. The rising numbers of chronic diseases and injuries also contribute to the segment's growth. Due to the high volume of operations conducted in hospitals, moist dressings like foam dressings, alginate dressings, hydrocolloid dressings, and film dressings are frequently used to treat conditions like ulcers caused by pressure, diabetic foot ulcers, surgical & traumatic wounds, and other. Furthermore, the substantial incidence of hospital-acquired infections (HAIs) will fuel segment growth.Product Outlook
On the basis of product, the market is segmented into foam dressings, hydrocolloid dressings, film dressings, alginate dressings, hydrogel dressings, collagen dressings, and other. The collagen dressings segment garnered a significant revenue share in the market in 2022. Collagen dressing is a new technique used to treat necrotic or partial-thickness wounds, second-degree burns, and skin grafting, among other conditions. Although collagen dressings cannot be used to treat all injuries, a special diagnosis must be performed to determine if they can be used. These dressing procedures promote the formation of human collagen at the lesion area. In addition to regulating the temperature at the location of the wound, collagen dressings also assist in fibroblast formation.Chronic Wounds Type Outlook
Under chronic wounds application, the market is further classified into diabetic foot ulcers, pressure ulcers, venous leg ulcers, and other. In 2022, the diabetic foot ulcers segment witnessed the largest revenue share in the market. This is attributable to the global increase in the number of diabetic patients. Diabetic foot ulcers often exude fluids, which can cause traditional dry dressings to adhere to the wound, leading to pain and tissue damage during dressing changes. Moist dressings are less likely to adhere to the wound bed, making dressing changes gentler and less traumatic. Uncontrolled diabetes can result in blindness, kidney failure, heart attack, liver failure, and removal of limbs due to untreated foot ulceration.Acute Wounds Type Outlook
Under acute wounds application, the market is further divided into surgical & traumatic wounds and burns. In 2022, the surgical & traumatic wounds segment held the highest revenue share in the market. The rise in injury incidence is anticipated to increase the number of individuals seeking treatment for chronic injuries. Patients experience less discomfort when surgical and trauma wounds are treated with moist wound dressings because the moist environment prevents the wound from drying. In addition, the substantial number of road accidents and the resultant increase in injuries pose a global health risk. Accidents resulting in severe and grievous injuries have ensured a need for wound care products.Regional Outlook
Region-wise, the market is analysed across North America, Europe, Asia Pacific, and LAMEA. In 2022, the North America region led the market by generating maximum revenue share. Due to the existence of the target population and increased levels of patient awareness. As most chronic wounds, such as diabetic foot and pressure ulcers, increase in the region, the market is anticipated to expand further. According to the Agency for Healthcare Research and Quality, around 2.5 million patients suffer from pressure ulcers annually. In addition to the presence of significant market players and their extensive distribution network, the simple accessibility of products will also contribute to expanding the regional market.The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Coloplast Group, Medline Industries, Inc., Smith & Nephew PLC, Convatec, Inc., Essity AB, Integra LifeSciences Holdings Corporation, Cardinal Health, Inc., Molnlycke Health Care AB, 3M Company, B. Braun Melsungen AG
Scope of the Study
Market Segments Covered in the Report:
By Application (Volume, Million Units, USD Million, 2019-2030)- Chronic Wounds
- Diabetic Foot Ulcers
- Pressure Ulcers
- Venous Leg Ulcers
- Others
- Acute Wounds
- Surgical & Traumatic Wounds
- Burns
- Hospitals
- Specialty Clinics
- Home Healthcare
- Others
- Foam Dressings
- Film Dressings
- Hydrogel Dressings
- Alginate Dressings
- Hydrocolloid Dressings
- Collagen Dressings
- Others
- North America
- US
- Canada
- Mexico
- Rest of North America
- Europe
- Germany
- UK
- France
- Russia
- Spain
- Italy
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- South Korea
- Singapore
- Malaysia
- Rest of Asia Pacific
- LAMEA
- Brazil
- Argentina
- UAE
- Saudi Arabia
- South Africa
- Nigeria
- Rest of LAMEA
Key Market Players
List of Companies Profiled in the Report:
- Coloplast Group
- Medline Industries, Inc.
- Smith & Nephew PLC
- Convatec, Inc.
- Essity AB
- Integra LifeSciences Holdings Corporation
- Cardinal Health, Inc.
- Molnlycke Health Care AB
- 3M Company
- B.Braun Melsungen AG
Unique Offerings
- Exhaustive coverage
- The highest number of Market tables and figures
- Subscription-based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
Table of Contents
Chapter 1. Market Scope & Methodology
Chapter 2. Market at a Glance
Chapter 3. Market Overview
Chapter 4. Global Moist Wound Dressings Market by Application
Chapter 5. Global Moist Wound Dressings Market by End-use
Chapter 6. Global Moist Wound Dressings Market by Product
Chapter 7. Global Moist Wound Dressings Market by Region
Chapter 8. Company Profiles
Companies Mentioned
- Coloplast Group
- Medline Industries, Inc.
- Smith & Nephew PLC
- Convatec, Inc.
- Essity AB
- Integra LifeSciences Holdings Corporation
- Cardinal Health, Inc.
- Molnlycke Health Care AB
- 3M Company
- B. Braun Melsungen AG
Methodology
LOADING...
